NVNO (enVVeno Medical Corp.) Net Profit

Corporate emblem and logo of envveno.com (NVNO)

enVVeno Medical (NVNO) bioprosthesis production in California relies on strict climate control and alloy inventories. The company's gross profit clearly demonstrates the rate of change in business value, with the -0.01 mark serving as a current indicator. Financial pressure is driven by testing costs and expectations regarding the FDA verdict, while human capital potential is secured by recruiting leading bioengineers and surgeons.

NVNO: enVVeno Medical Net Profit 07/04/2022 - 11/01/2026

Financial and market metric breakdowns for enVVeno Medical Corp. (NVNO)

- current quotes and average value forecast:
Market Chart enVVeno Corp|NVNO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization enVVeno Corp|NVNO - Total Company Value
- book capitalization data:
Net Assets per Single Share enVVeno Medical|NVNO - Book Capitalization|Market Capitalization to Book Value envveno.com|NVNO - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity enVVeno Medical|NVNO - Long-Term Debt to Capital|Current Liabilities to Capital enVVeno Medical Corporation|NVNO - Company Aggregate Debts|Debt to Book Value Ratio enVVeno Corp|NVNO - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings enVVeno Medical|Quick Liquidity Indicator envveno.com
- earnings and valuation multiples information:
NVNO - Net Profit
Fundamental valuation:enVVeno Corp
Product sample of enVVeno Medical

enVVeno Medical (NVNO) profit reflects the final financial result net of all operating expenses and taxes, allowing investors to assess the actual efficiency of cash flow generation. Analyzing the company's net income reveals how supply chain disruptions and export sanctions on enVVeno Medical (NVNO) medical valves are constraining the business's bottom-line growth.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income IRADIMED IRMD|EMBC - Net Income|Tandem Diabetes - Net Profit|Company Net Income Axogen Surgical|SIBN: Net Profit|Company Profit OFIX|BVS (Bioventus) - Net Profit|OrthoPediatrics Inc. (KIDS) - Net Financial Result|Net Profit TMCI|Net Income Strata Medical SRTA|Net Profit CARL (Carlsmed Inc)|Net Profit rxsight.com RXST|CLPT - Company Net Income|STXS: Company Net Income|STIM (NeuroStar) - Net Income|Sight Sciences Inc - Final Profit|OBIO (Orchestra BioMed) - Net Profit|Company Net Income Anika ANIK|Company Net Income InspireMD (NSPR)|zhjmedical.com (ZJYL) - Annual Net Income|Vivani Medical - Net Income|Net Profit Xtant Medical Holdings, Inc. XTNT|NeuroOne Medical Technologies - Net Profit|Net Financial Result Modular Medical MODD|Myomo (MYO) - Company Net Income|Profit After Tax COCH (Envoy Medical Inc.)|Company Net Income Vivos Therapeutics, Inc|Net Income SINTX Technologies (SINT)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOL: Net Profit|Company Net Income Dynatronics (DYNT)|Company Net Income Paragon 28 Inc.|Company Profit INVO (INVO Bio)